VAERS reports by lot

GSK Varicella/Shingles lot K2ZY4: VAERS reports

49 VAERS reports list lot K2ZY4 as a GSK Varicella/Shingles vaccine, received between 2018-09-01 and 2020-12-07. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
49
Reports
2%
Marked serious
0
With a death outcome
13
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)6628%
Injection-site / Local reaction3113%
Neurological2912%
Gastrointestinal2410%
Musculoskeletal2410%
Dermatological (non-injection-site)229%
Cardiac / Cardiovascular167%
Allergic / Anaphylactic104%
Psychiatric / Neuropsychiatric63%
Respiratory42%
Autoimmune / Immune-mediated10%

Where reports came from

U.S. state of the reporter, where given (top 12).

New York7
Pennsylvania6
Michigan4
Wisconsin3
Georgia3
Massachusetts3
North Carolina2
California2
Virginia2
Oklahoma1
Missouri1
Illinois1

Reports by month received

2018-091
2018-1216
2019-019
2019-027
2019-036
2019-043
2019-051
2019-071
2019-081
2019-111
2019-121
2020-021
2020-121

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.